News
MGRM
2.070
-2.82%
-0.060
MONOGRAM ORTHOPAEDICS INC SEES SUPPLEMENT RELATED TO OFFER OF UP TO 6.21 MLN SHARES OF COMMON STOCK- SEC FILING
Reuters · 17h ago
Monogram Orthopaedics reports Q1 results
Monogram Orthopaedics reports Q1 results May 15, 2024. Q1 GAAP EPS of -$ in-line. Cash and cash equivalents totaled $ as of March 31, 2024, compared to $ as of December 31, 2023. Monogram orthopaedic, Inc. (MGRM)
Seeking Alpha · 2d ago
Monogram Orthopaedics To Merge Subsidiary, Monogram Technologies Into Monogram Orthopaedics; Company Changes Name To Monogram Technologies
Benzinga · 3d ago
MONOGRAM ORTHOPAEDICS INC - COMPLETES CORPORATE NAME CHANGE TO MONOGRAM TECHNOLOGIES
Reuters · 3d ago
Monogram Orthopaedics Reports Quarterly Achievements and Plans Q&A
TipRanks · 4d ago
Monogram Engages CRO To Oversee Clinical Trial For mBôs Robot
Benzinga · 5d ago
Weekly Report: what happened at MGRM last week (0506-0510)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Monogram Orthopaedics (NASDAQ:MGRM) stock increased by 19.1% to $2.31 during Monday's pre-market session. Allarity Therapeutics shares rose by 13.99% during the session. Sunshine Biopharma and Addex Therapeutic shares also moved upwards. GlycoMimetics shares decreased by 78.7% in the pre- market session.
Benzinga · 05/06 12:06
Weekly Report: what happened at MGRM last week (0429-0503)?
Weekly Report · 05/06 10:19
Monogram Orthopaedics Advances with FDA Insights and Trials
TipRanks · 05/01 11:13
MONOGRAM ORTHOPAEDICS - BELIEVES FEEDBACK WAS COMPREHENSIVE AND WILL BE ADVANTAGEOUS FOR PREPARING SUCCESSFUL 510(K) SUBMISSION TO OBTAIN CLEARANCE
Reuters · 05/01 11:10
Weekly Report: what happened at MGRM last week (0422-0426)?
Weekly Report · 04/29 10:23
Weekly Report: what happened at MGRM last week (0415-0419)?
Weekly Report · 04/22 10:18
NXPL, MGRM and OCX among pre-market losers
U.S. Economy NXPL, MGRM and OCX among pre-market losers. Marinus Pharmaceuticals -74% provides update on the phase 3 RAISE trial. NextPlat Corp -19% as FDA puts Phase 1 schizophrenia study on hold.
Seeking Alpha · 04/15 12:21
Weekly Report: what happened at MGRM last week (0408-0412)?
Weekly Report · 04/15 10:12
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
JPMorgan Chase & Co. Shares dipped 5.1% to $185.49 following first-quarter earnings on Friday. PaxMedica, Inc. Shares jumped 143% after the company reported better-than-expected results on Thursday. Rent the Runway shares jumped 162% on Thursday after reporting mixed results.
Benzinga · 04/12 18:47
BUZZ-U.S. STOCKS ON THE MOVE-Virco, Argan, State Street
Wall Street's main stock indexes fell on Friday. The Dow Jones Industrial Average was down 1.48% and the S&P 500 and Nasdaq Composite were also down. Some big banks dipped after reporting dour quarterly results. The top three growth stocks and chipmakers receded. Virco, Argan and State Street were up.
Reuters · 04/12 18:20
12 Health Care Stocks Moving In Friday's Intraday Session
PaxMedica stock increased by 110.9% to $0.87 during Friday's regular session. Q32 Bio (NASDAQ:QTTB) shares rose 23.89% during the session. Cyclacel Pharmaceuticals shares increased by 20.45%. SenesTech and Motus GI Hldgs were among the losers.
Benzinga · 04/12 16:31
BUZZ-U.S. STOCKS ON THE MOVE-Exxon, Oil stocks, Nextplat
The blue-chip Dow and the S&P 500 were on track for weekly losses on Friday. Most megacap growth stocks and chipmakers retreated, while some big banks fell after reporting dour quarterly earnings. The Dow Jones Industrial Average was down 0.84% at 38,136.43 and the Nasdaq Composite was down 1.08%.
Reuters · 04/12 16:23
More
Webull provides a variety of real-time MGRM stock news. You can receive the latest news about Monogram Orthopaedics Inc through multiple platforms. This information may help you make smarter investment decisions.
About MGRM
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.